Vivus Inc has released promising results for their Phase 3
clinical trial CONQUER which was designed to evaluate the safety and
efficacy of their new investigational weight loss drug Qnexa. Despite
Qnexa’s promising results, the FDA is fearful of unpredictable and
dangerous side effects and has been hesitant to approve many weight loss
products, including Qnexa...
